Philip Marder
- Molecular Biology
- Immunology top 10%
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging
- Physiology
- Co-authors
- Lisa J. GreenStephen M. SpaetheChristopher A. SlapakJon R. SchmidtkeLarry L. FroelichRichard M. SchultzEric R. ProssnitzAlexis Traynor‐Kaplan
- Topics
- Monoclonal and Polyclonal Antibodies Research (9 papers)Immune Response and Inflammation (9 papers)Asthma and respiratory diseases (9 papers)
- Journals
- The Journal of ImmunologyClinical Cancer ResearchBiochemical and Biophysical Research Communications
- Partner nations
- United StatesNetherlandsSingapore
In The Last Decade
Philip Marder
45 papers receiving 889 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 418
- Immunology 265
- Oncology 237
- Radiology, Nuclear Medicine and Imaging 101
- Physiology 98
Countries citing papers authored by Philip Marder
This map shows the geographic impact of Philip Marder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Marder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Marder more than expected).
Fields of papers citing papers by Philip Marder
This network shows the impact of papers produced by Philip Marder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Marder. The network helps show where Philip Marder may publish in the future.
Co-authorship network of co-authors of Philip Marder
This figure shows the co-authorship network connecting the top 25 collaborators of Philip Marder. A scholar is included among the top collaborators of Philip Marder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Marder. Philip Marder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Flow cytometry in drug discovery and development | 4 |
| 2 | 57 | |
| 3 | 55 | |
| 4 | 7 | |
| 5 | 72 | |
| 6 | 20 | |
| 7 | 11 | |
| 8 | 16 | |
| 9 | 43 | |
| 10 | 162 | |
| 11 | 40 | |
| 12 | 8 | |
| 13 | 2 | |
| 14 | 16 | |
| 15 | 10 | |
| 16 | 29 | |
| 17 | 56 | |
| 18 | 7 | |
| 19 | 8 | |
| 20 | 7 |
About Philip Marder
Philip Marder is a scholar working on Immunology and Allergy, Immunology and Hematology, having authored 45 papers that have together received 929 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Immune Response and Inflammation (9 papers) and Asthma and respiratory diseases (9 papers). The work is most often cited by research in Immunology and Allergy (97 citations), Immunology (265 citations) and Oncology (237 citations). Philip Marder has collaborated with scholars based in United States, Netherlands and Singapore. Frequent co-authors include Lisa J. Green, Stephen M. Spaethe, Christopher A. Slapak, Jon R. Schmidtke, Larry L. Froelich, Richard M. Schultz, Eric R. Prossnitz, Alexis Traynor‐Kaplan, L D Apelgren and Raymond F. Brown. Their work appears in journals such as The Journal of Immunology, Clinical Cancer Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.